Linacre Investments Limited Delivers Record-Breaking Returns for 2024
Linacre Investments Reports Unprecedented Returns, Fueled by Bold Private Wealth Strategies and Early Bets on Groundbreaking Sectors
LONDON, UNITED KINGDOM / ACCESSWIRE / January 8, 2025 / Linacre Investments has announced record-breaking returns for 2024, underscoring the firm's successful strategy in private wealth management and early-stage investments. The company's performance highlights the effectiveness of its tailored approach to wealth management, which combines private equity investments in transformative sectors with a focus on emerging technologies.
The firm's success was largely attributed to its investments in sectors such as space exploration, satellite internet, artificial intelligence (AI), and fintech, as well as its strategic positions in private companies that are yet to list on public markets. These industries, which have seen significant growth over the past year, were identified early by Linacre's team, positioning the firm's clients to benefit from high-value opportunities that align with long-term market trends.
Linacre's forward-looking approach to private equity, which focuses on high-growth areas at the forefront of technological innovation, was central to its record returns. In particular, the firm's early investments in digital assets and blockchain technology, beginning in 2016, have proven particularly successful. With the recent favorable political developments in the U.S., including a supportive regulatory environment for digital assets, these investments have seen significant appreciation, contributing to Linacre's strong performance in 2024.
The firm's strong returns have also resulted in substantial inflows from both institutional and retail clients, particularly in Europe, South Africa, and the Middle East. In response to growing demand, Linacre is expanding its team, hiring additional analysts and account managers to support the firm's increased client base.
Alexander Rose, Head of Global Equities at Linacre Investments, commented:"2024 has been a milestone year for us, as our strategic investments in sectors such as Space Exploration, AI, fintech, and blockchain have positioned us for continued long-term success. The favorable political climate, especially in the U.S., has further accelerated growth, and as our client base continues to grow, we are expanding our team to ensure we can continue delivering personalized, high-quality service to all our clients."
Linacre Investments remains committed to providing bespoke wealth management solutions and leveraging emerging opportunities in the global investment landscape. With its continued growth and an eye on new opportunities in 2025, the firm is poised to maintain its position as a leader in private wealth management.
About Linacre Investments
Linacre Investments Limited is a global wealth management firm, with offices in the Isle of Man, Australia and London. Specializing in private equity, bespoke wealth strategies, and early-stage investments in emerging technologies. With a proven track record of delivering superior returns for institutional and retail clients alike, Linacre is known for its forward-thinking approach to wealth management. The firm offers a comprehensive suite of investment services designed to navigate the complexities of today's markets while identifying opportunities for sustainable long-term growth.
For media enquiries, please contact:
Mrs. Sarah Bramston (Public Relations Officer)
Linacre Investments Ltd
Email: media@linacreinvestments.com
Web: www.linacreinvestments.com
Tel: +44(0)845 004 7888
Address: 40 Bank Street, London, E14 5AB, United Kingdom
SOURCE: Linacre Investments Limited
View the original press release on accesswire.com
Linacre Investments Limited

Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring
Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom